spacer
spacer

PDBsum entry 2k2d

Go to PDB code: 
protein metals links
Metal binding protein PDB id
2k2d

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
47 a.a. *
Metals
_ZN
* Residue conservation analysis
PDB id:
2k2d
Name: Metal binding protein
Title: Solution nmr structure of c-terminal domain of human pirh2. Northeast structural genomics consortium (nesg) target ht2c
Structure: Ring finger and chy zinc finger domain-containing protein 1. Chain: a. Fragment: c-terminal domain: residues 187-261. Synonym: zinc finger protein 363, ch-rich-interacting match with plag1, androgen receptor n-terminal-interacting protein, p53-induced ring-h2 protein, hpirh2, ring finger protein 199. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: rchy1, arnip, chimp, pirh2, rnf199, znf363. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
NMR struc: 15 models
Authors: A.Lemak,Y.Sheng,M.Karra,S.Srisailam,R.C.Laister,S.Duan, C.H.Arrowsmith,Northeast Structural Genomics Consortium (Nesg)
Key ref:
Y.Sheng et al. (2008). Molecular basis of Pirh2-mediated p53 ubiquitylation. Nat Struct Biol, 15, 1334-1342. PubMed id: 19043414 DOI: 10.1038/nsmb.1521
Date:
31-Mar-08     Release date:   15-Apr-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q96PM5  (ZN363_HUMAN) -  RING finger and CHY zinc finger domain-containing protein 1 from Homo sapiens
Seq:
Struc:
261 a.a.
47 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.3.2.27  - RING-type E3 ubiquitin transferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine

 

 
DOI no: 10.1038/nsmb.1521 Nat Struct Biol 15:1334-1342 (2008)
PubMed id: 19043414  
 
 
Molecular basis of Pirh2-mediated p53 ubiquitylation.
Y.Sheng, R.C.Laister, A.Lemak, B.Wu, E.Tai, S.Duan, J.Lukin, M.Sunnerhagen, S.Srisailam, M.Karra, S.Benchimol, C.H.Arrowsmith.
 
  ABSTRACT  
 
Pirh2 (p53-induced RING-H2 domain protein; also known as Rchy1) is an E3 ubiquitin ligase involved in a negative-feedback loop with p53. Using NMR spectroscopy, we show that Pirh2 is a unique cysteine-rich protein comprising three modular domains. The protein binds nine zinc ions using a variety of zinc coordination schemes, including a RING domain and a left-handed beta-spiral in which three zinc ions align three consecutive small beta-sheets in an interleaved fashion. We show that Pirh2-p53 interaction is dependent on the C-terminal zinc binding module of Pirh2, which binds to the tetramerization domain of p53. As a result, Pirh2 preferentially ubiquitylates the tetrameric form of p53 in vitro and in vivo, suggesting that Pirh2 regulates protein turnover of the transcriptionally active form of p53.
 
  Selected figure(s)  
 
Figure 2.
(a) Pirh2 NTD. N lobe shows the interleaved Zn1 and Zn2 sites and a four-cysteine-coordinated Zn3 site. C lobe shows left-handed -spiral structure with three CCHC motifs coordinating Zn4, Zn5 and Zn6. (b) Pirh2 RING domain, showing the interleaved Zn7 and Zn8 sites. (c) Pirh2 CTD, showing Zn9 site coordinated by four cysteines. The nine zinc atoms are shown as spheres.
Figure 7.
Top, domains of tetrameric p53 interacting with those of Pirh2. UBE2D2-Pirh2 RING domain orientations are based on the crystal structure of the homologous complex formed between UBCH7 and the c-Cbl RING domain^20. Bottom, active site cysteine of UBE2D2, charged with ubiquitin, is shown in red.
 
  The above figures are reprinted by permission from Macmillan Publishers Ltd: Nat Struct Biol (2008, 15, 1334-1342) copyright 2008.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21317885 H.Wu, S.L.Pomeroy, M.Ferreira, N.Teider, J.Mariani, K.I.Nakayama, S.Hatakeyama, V.A.Tron, L.F.Saltibus, L.Spyracopoulos, and R.P.Leng (2011).
UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53.
  Nat Med, 17, 347-355.  
21284766 Z.Wang, B.Yang, L.Dong, B.Peng, X.He, and W.Liu (2011).
A novel oncoprotein Pirh2: rising from the shadow of MDM2.
  Cancer Sci, 102, 909-917.  
  20516128 A.C.Joerger, and A.R.Fersht (2010).
The tumor suppressor p53: from structures to drug discovery.
  Cold Spring Harb Perspect Biol, 2, a000919.  
20404858 C.L.Brooks, and W.Gu (2010).
New insights into p53 activation.
  Cell Res, 20, 614-621.  
  20633357 G.A.Bermejo, and M.Llinás (2010).
Structure-oriented methods for protein NMR data analysis.
  Prog Nucl Magn Reson Spectrosc, 56, 311-328.  
20074047 S.J.Goldenberg, J.G.Marblestone, M.R.Mattern, and B.Nicholson (2010).
Strategies for the identification of ubiquitin ligase inhibitors.
  Biochem Soc Trans, 38, 132-136.  
19899083 T.Srikumar, S.M.Jeram, H.Lam, and B.Raught (2010).
A ubiquitin and ubiquitin-like protein spectral library.
  Proteomics, 10, 337-342.  
20008555 Y.S.Jung, G.Liu, and X.Chen (2010).
Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.
  Mol Cell Biol, 30, 1041-1048.  
19483087 C.A.Corcoran, J.Montalbano, H.Sun, Q.He, Y.Huang, and M.S.Sheikh (2009).
Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.
  J Biol Chem, 284, 21955-21970.  
19584248 E.Tai, and S.Benchimol (2009).
TRIMming p53 for ubiquitination.
  Proc Natl Acad Sci U S A, 106, 11431-11432.  
19597829 N.L.Lehman (2009).
The ubiquitin proteasome system in neuropathology.
  Acta Neuropathol, 118, 329-347.  
20011534 W.Lee, Y.Zhang, K.Mukhyala, R.A.Lazarus, and Z.Zhang (2009).
Bi-directional SIFT predicts a subset of activating mutations.
  PLoS One, 4, e8311.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer